Navigation Links
Swelling of Prostate Gland Prevented with New drug

Estrogen regulating drugs might aid in prevention of enlargement of the prostate gland in older men according to Australian scientists. //

Results of animal studies that were presented at a medical conference in London showed that an experimental estrogen-regulating drug prevented the swelling of the prostate gland which occurs as men age.

Professor Gail Risbridger, of Monash University in Melbourne said, “We still have to try the drugs in humans, but so far these are very promising results.”

“This work holds out the possibility that we may be able to help patients with benign disease as well as men with prostate cancer by using these designer drugs.”

Enlarged prostate, or benign prostate hyperplasia (BPH) is a common disease in men over 60 causing urinary problems, infections and pain.

Although estrogen is generally considered a female hormone it also plays a role in the development of the prostate gland having both positive and negative effects.

Risbridger said, “There are two things that estrogens do, good and bad, but in different diseases.”

The bad effect is that the hormone can cause malignancy but on the positive side it can stop BPH from developing.

On testing an estrogen receptor-beta agonist on transgenic mice with BPH Risbridger and her team found that the drug activated just one of the two cell receptors for the hormone to produce the positive impact. This was presented at the Society for Endocrinology conference.

The scientists found that regulating the estrogen receptor beta stopped the development of benign prostate hyperplasia, while the negative effects were due to switching on the estrogen receptor alpha.

She said, “When you give one of the estrogen selective drugs that only activates a particular type of estrogen receptor, beta, you can prevent the hyperplasia from developing.”

The drug was found to stop the development of the illness and improve the health of the animals which had existing BPH.

Risbridger added, “Ideally, we would want to promote the good effects of estrogen receptor beta and block the bad effects of estrogen receptor alpha.”

“It’s interesting work, and we are pleased that preclinical testing may translate into real benefits for patients.”

Source-Medndia
NLA
'"/>




Related medicine news :

1. Swelling increases stroke risk with high B.P.
2. Do Not Neglect Your Abdominal Pain/ Swelling - Help Your Doctor In Early Cancer Detection
3. Brain Swelling Key to Reducing Stroke Fatalities
4. Surgeon Develops Procedure to Prevent Arm Swelling in Breast Cancer Patients
5. Cancer Doctors Okays Controversial Prostate Therapy
6. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
7. New Prostate Cancer Vaccine Shows Promise
8. Hormone Therapy applicable for Prostate Cancer
9. Prostate cancer and Vitamins
10. Response to chemotherapy could be measured by Prostate-Specific Antigen Doubling Time
11. Early Detection Of Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2017)... ... 2017 , ... Janet Schloz is still in shock after receiving a $2,500 Academic Award from ... long time,” she said. , She thinks the coming week is going to be a ... would have to help my students.” , The award will allow the 4th grade teacher ...
(Date:3/27/2017)... ... March 27, 2017 , ... According to the American Cancer ... stages, is more than 95%. Once the cancer spreads to other organs, bones, or ... find out how to avoid this latter group, tune in to Lifestyle Magazine ...
(Date:3/27/2017)... ... March 27, 2017 , ... The Anaheim Hills office accelerates and supports FNCC’s ... added 10 new sales professionals over the past 6 months and is continuing to ... hires over the course of 2017. , “This new office is a direct ...
(Date:3/27/2017)... ... March 27, 2017 , ... Sodium determination is consistently ... and require expert user knowledge. In a live webinar on April 11th and ... yet highly accurate, determination of sodium. , It has long been known that ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... announce the launch of a months-long rebranding effort. This includes the introduction of ... focus group discussions and market research, we learned that a simple, proactive approach ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 27, 2017 The global ... 16.0 billion by 2025, according to a new study ... chronic diseases is anticipated to be responsible for the ... widens the scope for growth during the forecast period. ... which is highly susceptible to chronic diseases, is presumed ...
(Date:3/27/2017)... , March 27, 2017 ... as the NASDAQ Composite closed the trading session up ... and the S&P 500 was down 0.08%. US markets ... sectors finishing the day in green. Pre-market today, Stock-Callers.com ... Medical Group N.V. (NASDAQ: WMGI), Amedica Corporation (NASDAQ: AMDA), ...
(Date:3/27/2017)... 2017  iCAD (Nasdaq: ICAD), an industry-leading provider ... therapy for the early identification and treatment of ... Premarket Approval (PMA) from the U.S. Food and ... first-of-its-kind, concurrent-read computer aided detection solution for digital ... available on the PowerLook® Breast Health Solutions platform.  ...
Breaking Medicine Technology: